IL125993A0 - Iron complexes of nitrogen-containing macrocyclic ligands - Google Patents

Iron complexes of nitrogen-containing macrocyclic ligands

Info

Publication number
IL125993A0
IL125993A0 IL12599397A IL12599397A IL125993A0 IL 125993 A0 IL125993 A0 IL 125993A0 IL 12599397 A IL12599397 A IL 12599397A IL 12599397 A IL12599397 A IL 12599397A IL 125993 A0 IL125993 A0 IL 125993A0
Authority
IL
Israel
Prior art keywords
nitrogen
iron complexes
macrocyclic ligands
containing macrocyclic
ligands
Prior art date
Application number
IL12599397A
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of IL125993A0 publication Critical patent/IL125993A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
IL12599397A 1996-03-13 1997-03-11 Iron complexes of nitrogen-containing macrocyclic ligands IL125993A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61471096A 1996-03-13 1996-03-13
PCT/US1997/003348 WO1997033588A1 (en) 1996-03-13 1997-03-11 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide

Publications (1)

Publication Number Publication Date
IL125993A0 true IL125993A0 (en) 1999-04-11

Family

ID=24462404

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12599397A IL125993A0 (en) 1996-03-13 1997-03-11 Iron complexes of nitrogen-containing macrocyclic ligands

Country Status (10)

Country Link
EP (1) EP0888115A1 (en)
JP (1) JP2000507929A (en)
KR (1) KR19990087783A (en)
AU (1) AU2065697A (en)
BR (1) BR9707978A (en)
CA (1) CA2248964A1 (en)
CZ (1) CZ277698A3 (en)
IL (1) IL125993A0 (en)
NO (1) NO984165L (en)
WO (1) WO1997033588A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1155019B1 (en) 1999-01-25 2005-12-07 National Jewish Medical and Research Center Substituted porphyrins and their therapeutic use
US20030032634A1 (en) 2001-06-01 2003-02-13 Piganelli Jon D. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
EP1185312B1 (en) * 1999-05-27 2005-03-23 Monsanto Company Biomaterials modified with superoxide dismutase mimics
US20050175580A1 (en) * 2001-01-05 2005-08-11 Daniela Salvemini Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
WO2002058686A2 (en) * 2001-01-26 2002-08-01 Metaphore Pharmaceuticals, Inc. Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
US8468189B2 (en) 2006-11-08 2013-06-18 Okinawa Institute Of Science And Technology Promotion Corporation Iterated variational regularization combined with componentwise regularization
EP2732817B1 (en) 2008-05-23 2016-08-24 National Jewish Health A compound for use in treating injury associated with exposure to phosgene or chlorine gas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0145953B1 (en) * 1991-07-19 1998-08-17 제임스 클리프튼 보올딩 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
EP0756495A1 (en) * 1994-04-22 1997-02-05 Monsanto Company Diagnostic image analysis with metal complexes
US6525041B1 (en) * 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide

Also Published As

Publication number Publication date
CA2248964A1 (en) 1997-09-18
KR19990087783A (en) 1999-12-27
NO984165L (en) 1998-11-10
JP2000507929A (en) 2000-06-27
WO1997033588A1 (en) 1997-09-18
CZ277698A3 (en) 1999-02-17
BR9707978A (en) 1999-07-27
EP0888115A1 (en) 1999-01-07
NO984165D0 (en) 1998-09-10
AU2065697A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
GB9711237D0 (en) Organomettallic Complexes
HUP0400256A3 (en) Modified tie-2-receptor ligands
AU3558499A (en) Ancillary ligands and metal complexes thereof
IL126546A0 (en) Inclusion complexes of aryl-heterocyclic salts
HUP0104654A3 (en) Bridged metal complexes
EP1032388A4 (en) Novel metal complexes
GB9612130D0 (en) Novel group IV metal complexes
AU8499798A (en) Compositions and metal complexes having ancillary ligands
ZA988503B (en) Mixed bed iron reduction process
EP1032387A4 (en) Novel metal complexes
PL327505A1 (en) Production of biscyclopentadienylodiene complexes
EP0856009A4 (en) Cd6 ligand
IL125993A0 (en) Iron complexes of nitrogen-containing macrocyclic ligands
IL125889A0 (en) Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
GB2314078B (en) Biodegradation of iron cyanide complexes
GB9619579D0 (en) Seaming iron
ZA9610314B (en) Metal-ligand complex catalyzed processes
GB2300260B (en) Determination of ligand binding affinity
GB9513342D0 (en) Complexes
EP1039906A4 (en) Novel metal complexes
AP9701141A0 (en) Antimalarial organometallic iron complexes
AU123886S (en) Iron
GB2319782B (en) Iron based powder
GB9716653D0 (en) Novel transition metal complexes
EP1017858A4 (en) Mixed bed iron reduction process